GlassScriptPhysician profile
Joseph V Visceglia
NPI 1477177525
$4,666.90
in general payments reported to CMS, 2019-2025
36 companies · $936 in 2025
The $936 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $360 · 2022: $1,130 · 2023: $1,173 · 2024: $1,067 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,176.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $754.79 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $678.91 | 2021-2025 | |
| Glaxosmithkline, LLC. | $644.07 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $370.05 | 2021-2025 | |
| Dexcom, INC. | $239.62 | 2023-2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $223.99 | 2021-2024 | Xarelto |
| Abbott Laboratories | $176.05 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Astrazeneca Pharmaceuticals LP | $150.02 | 2021-2025 | Airsupra, Farxiga |
| Exact Sciences Corporation | $128.33 | 2023-2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $125.73 | 2022-2024 | Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $103.24 | 2022 | |
| Astellas Pharma US INC | $87.77 | 2023-2024 | Veozah |
| Lilly USA, LLC | $76.76 | 2022-2024 | Jardiance |
| Cequr Corporation | $75.41 | 2024-2025 | Cequr Simplicity |
| Takeda Pharmaceuticals U.S.A., INC. | $67.34 | 2021-2023 | Trintellix |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Visceglia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.